RecallClass 3 · Action within 5 days

Class 3 Medicines Recall: Bayer Plc, Various Products, EL(26)A/12

Issued 12 Mar 2026 · EL(26)A/12 · Bayer Plc

Read and act on the official notice on GOV.UK

Class 3 recall — Action within 5 days. The MHRA uses Class 3 when: The defect is unlikely to cause harm to the patient.
What all four recall classes mean
ClassActionThe MHRA's definition
Class 1Immediate actionThe defect presents a risk of death or disability.
Class 2Action within 48 hoursThe defect may cause mistreatment or harm to the patient, but it is not life-threatening or serious.
Class 3 this recallAction within 5 daysThe defect is unlikely to cause harm to the patient.
Class 4Caution in useUsually minor defects in packaging or other printed materials.

A Class 1 recall usually comes with a National Patient Safety Alert. Source: MHRA, safety communications.

The MHRA's summary

Bayer Plc is recalling all stock of the products listed in this notification as a precautionary measure due to the identification of an impurity above the acceptable limit. The recall is at pharmacy and wholesaler level.

Affected batches

As listed by the MHRA, exactly as published. Always check against the GOV.UK notice before acting.

Batch numberExpiryPack sizeFirst distributed
Gastrografin gastroenteral solution
MA04HM902/202810x100ml01/05/2024
MA04JKA03/202810x100ml31/05/2024
MA04KFC04/202810x100ml30/07/2024
MA04KJ904/202810x100ml01/08/2024
MA04M6007/202810x100ml23/09/2024
MA04MLL08/202810x100ml04/11/2024
MA04MM909/202810x100ml15/12/2024
MA04MN909/202810x100ml19/01/2025
MA04NDU10/202810x100ml13/02/2025
MA04NNB11/202810x100ml06/03/2025
MA04PJL12/202810x100ml15/04/2025
MA04PLZ12/202810x100ml29/05/2025
MA04PMV01/202910x100ml11/07/2025
MA04RL202/202910x100ml14/08/2025
MA04RL302/202910x100ml15/09/2025
MA04S6C02/202910x100ml30/10/2025
MA04S6B02/202910x100ml03/10/2025
MA04S6T02/202910x100ml02/12/2025
MA04XJ807/202910x100ml09/01/2026
Urografin 150 Infusion
MA044UD03/20261x250ml09/02/2023
MA04A5803/20261x250ml27/06/2023
MA04BVD07/20261x250ml09/11/2023
MA04BVE07/20261x250ml23/01/2024
MA04HS802/20291x250ml04/06/2024
MA04L2M02/20291x250ml18/07/2024
MA04LTC05/20291x250ml27/08/2024
MA04NAL07/20291x250ml11/12/2024
MA04MK608/20291x250ml19/11/2024
MA04SJ309/20291x250ml03/07/2025
MA04NB810/20291x250ml23/04/2025
MA04UXS10/20291x250ml15/10/2025
MA04VPT05/20301x250ml12/01/2026
MA042CN05/20261x500ml24/06/2022
MA044U405/20261x500ml01/11/2022
MA048LU05/20261x500ml09/03/2023
MA04BV005/20261x500ml26/07/2023
MA04FRU05/20261x500ml12/03/2024
MA044U907/20261x500ml02/03/2023
MA04TLV03/20301x500ml29/07/2025
Urografin 150 Injection
MA042JA06/202610x10ml28/07/2022
MA046UT06/202610x10ml19/12/2022
MA0496X06/202610x10ml29/03/2023
MA04AP006/202610x10ml08/08/2023
MA04BX706/202610x10ml27/10/2023
MA04FHP06/202610x10ml13/06/2024
MA04KJB06/202610x10ml15/08/2024
MA04L4506/202610x10ml15/09/2024
MA04S8T02/203010x10ml17/06/2025
MA043T709/202610x20ml13/09/2022
MA046TS09/202610x20ml20/02/2023
MA0497C09/202610x20ml21/03/2023
MA04R4R09/202910x20ml25/04/2025

MHRA's audience tags: Dispensing GP practices, Pharmacy, Radiology

Pharmshark is not an official alerting route. Make sure your pharmacy receives alerts directly from the MHRA and through your organisation, and always act on the official GOV.UK notice.

Source: the MHRA on GOV.UK. Contains public sector information licensed under the Open Government Licence v3.0. Pharmshark is not affiliated with or endorsed by the MHRA.